当着夫的面被夫上司玩弄,最近免费中文字幕中文高清百度 ,超碰CAOPORON入口,精品国产日韩一区二区三区

上海莼試生物技術(shù)有限公司

主營產(chǎn)品: ELISA試劑盒,ELISA試劑盒價格,ELISA試劑盒報價

8

聯(lián)系電話

13585831301

您現(xiàn)在的位置: 上海莼試生物技術(shù)有限公司>>生化試劑>>其它生化試劑>> 氧化鐵1309-37-1售后服務(wù)

公司信息

聯(lián)人:
李小姐
話:
021-59541103
機:
13585831301
售后電話:
13585831301
真:
021-60443211
址:
上海市嘉定區(qū)嘉羅公路1661號
編:
網(wǎng)址:
鋪:
http://www.yixinui.com/st562820/
給他留言
氧化鐵1309-37-1售后服務(wù)
氧化鐵1309-37-1售后服務(wù)
參考價 面議
具體成交價以合同協(xié)議為準(zhǔn)
  • 型號
  • 品牌
  • 廠商性質(zhì) 經(jīng)銷商
  • 所在地 上海市

更新時間:2017-07-22 11:33:55瀏覽次數(shù):678

聯(lián)系我們時請說明是環(huán)保在線上看到的信息,謝謝!

【簡單介紹】
氧化鐵1309-37-1售后服務(wù)避光、干燥陰涼處封閉貯存,嚴禁與有毒、有害物品混放、混運。本品為非危險 產(chǎn)品可按一般化學(xué)品運輸,輕搬動輕放,防止日曬、雨淋!受熱、受潮、受光后易喪失活力,保存期短,因此貯存和運輸條件比較苛刻。?

公司提供的氧化鐵1309-37-1售后服務(wù)保證,貨源充足。嚴格的質(zhì)量控制體系,包括:優(yōu)級純,分析純,化學(xué)純,試劑級,基準(zhǔn)試劑,實驗純,教學(xué)試劑,高純試劑,色譜純,光譜純,電子純。各種包裝規(guī)格,并可提供包裝定制,咨詢訂購。
氧化鐵1309-37-1售后服務(wù)其他中文名稱: 三氧化二鐵;紅色氧化鐵;氧化高鐵;205鐵紅;磁性氧化鐵紅;燒褐鐵礦;鐵丹;紅粉;威尼斯紅 
英文名稱: Iron(III)oxide 
其他英文名稱: Ferric oxide;Iron oxide red;Red iron trioxide 
產(chǎn)品規(guī)格: 4N 
包裝:10克 
產(chǎn)品規(guī)格: AR,99% 
包裝:500克 
:1309-37-1
Fe2O3=159.69
級別:4N
含量:≥99.99%
級別:AR
含量:≥99.0%
鹽酸不溶物:≤0.02%
重金屬(以Cu計):≤0.01%
水溶物:≤0.1%
硫化銨不沉淀物:≤0.2%
總氮量:≤0.005%
硫酸鹽:≤0.08%
性狀:紫棕色粉末。溶于酸,不溶于水。相對密度5.12~5.24。熔點1565℃。zui小致死量(狗,皮下)30mG/kG。有刺激性
用途:生化研究。分析試劑。催化劑。拋光劑。顏料配制。玻璃濾片(綠色)著色。鐵氧體
保存:RT

產(chǎn)品名稱   
英文名稱      Iron(III)oxide
發(fā)貨上海
 

特點:
1.現(xiàn)貨直銷,當(dāng)天下單,當(dāng)天發(fā)貨。
2.產(chǎn)品優(yōu)質(zhì),到貨快,免費快遞。
3.售前、售中、售后服務(wù)好。
有全、新、優(yōu)、品、好五大特點:
全:公司提供上萬種產(chǎn)品,涵蓋了生物試劑,elisa試劑盒,標(biāo)準(zhǔn)品,培養(yǎng)基,原裝耗材,抗體、培養(yǎng)基、ATCC細胞等,基本上各種科研所需產(chǎn)品在我司都能找到。
新:產(chǎn)品更新速度較快,基本上每周都有新產(chǎn)品出現(xiàn)。
優(yōu):產(chǎn)品質(zhì)量好,投訴比較少。
品:公司代理sigma,amresco,oxoid,wako,R&D,RB,MBL,TCI,GIBIO,等國內(nèi)外。
好:我公司具有優(yōu)質(zhì)的技術(shù)團隊,產(chǎn)品一旦售出,實驗過程中遇到困難可提供在線技術(shù)咨詢。使您使用產(chǎn)品時沒有任何的后顧之憂。
我們提供試劑品牌有Merck、Spectrum、BioAssay Systems、Jaica、Scharlab、Sigma-Aldrich、Amresco、Amersham等試劑品牌,試劑純度高、規(guī)格多、包裝好,規(guī)格包括:優(yōu)級純,分析純,化學(xué)純,試劑級,基準(zhǔn)試劑,實驗純,教學(xué)試劑,高純試劑,色譜純,光譜純,電子純。

標(biāo)準(zhǔn)物質(zhì) 
酒石酸麥角胺(E1200000
精鋁光譜分析標(biāo)準(zhǔn)物質(zhì)(G02210~02214
精鋁成分分析標(biāo)準(zhǔn)物質(zhì)(G02209
精鋁成分分析標(biāo)準(zhǔn)物質(zhì)(G02208
精鋁成分分析標(biāo)準(zhǔn)物質(zhì)(G02207
精鋁成分分析標(biāo)準(zhǔn)物質(zhì)(G02206
精鋁成分分析標(biāo)準(zhǔn)物質(zhì)(G02205
精吡氟禾草靈乙腈溶液標(biāo)準(zhǔn)物質(zhì)061414
腈苯唑甲醇溶液標(biāo)準(zhǔn)物質(zhì)061 87
金槍魚中7種PCBs標(biāo)準(zhǔn)物質(zhì)(G10041
金槍魚中18種有機氯農(nóng)標(biāo)準(zhǔn)物質(zhì)(3710
金槍魚中14種有機氯農(nóng)標(biāo)準(zhǔn)物質(zhì)(3711
金礦石成分分析標(biāo)準(zhǔn)物質(zhì)(G072 0
金合歡素,刺槐黃素016 5-025
金合歡素,刺槐黃素016 5
金地質(zhì)成分分析標(biāo)準(zhǔn)物質(zhì)(G07229
金地質(zhì)成分分析標(biāo)準(zhǔn)物質(zhì)(G07228
結(jié)晶紫獸藥純度標(biāo)準(zhǔn)物質(zhì)( 81 
漿果赤霉素 III(P;巴卡亭-III020045
漿果赤霉素 III(P;巴卡亭-III02004-025
漿果赤霉素 III(P;巴卡亭-III02004
假馬齒莧皂苷II020075
假馬齒莧皂苷II02007
假馬齒莧皂苷I020065
假馬齒莧皂苷I02006

MeOSuc-Ala-Ala-Pro-Ala-chloromethylketone; MeOSuc-AAPA-CMK
N-[(4-Chlorophenyl)methyl]-2-[(2R,6S,8E)-5, 12-dioxo-2-phenyl-1-oxa-4-azacyclododec-8-en-6-yl]acetamide
2-[(3,5-Difluoro-4-hydroxyphenyl)amino]-7,8-dihydro-5,7-dimethyl-8-(3-methylbutyl)-6(5H)-pteridone
2-[(3,5-Difluoro-4-hydroxyphenyl)amino]-7,8-dihydro-5,7-dimethyl-8-(3-methylbutyl)-6(5H)-pteridone
4-[4-[(5-Nitro-2-furanyl)methylene]-3,5-dioxo-1-pyrazolidinyl]benzoic acid ethyl ester
4-[4-[(5-Nitro-2-furanyl)methylene]-3,5-dioxo-1-pyrazolidinyl]benzoic acid ethyl ester
4-(2-Hydroxyethylamino)-2-(4-methoxy-phenylamino)-pyrimidine hydrochloride
4-(2-Hydroxyethylamino)-2-(4-methoxy-phenylamino)-pyrimidine hydrochloride
1-(1,1-Dimethylethyl)-1-(4-methylphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
1-(1,1-Dimethylethyl)-1-(4-methylphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
4-[3,5-Diphenyl-4,5-dihydropyrazol-1-yl]benzenesulfonamide
4-[3,5-Diphenyl-4,5-dihydropyrazol-1-yl]benzenesulfonamide
2-Deoxy-2-[[(methylnitrosoamino)carbonyl]amino]-D-glucose
2-Deoxy-2-[[(methylnitrosoamino)carbonyl]amino]-D-glucose
2-Deoxy-2-[[(methylnitrosoamino)carbonyl]amino]-D-glucose
5-[1,2-Dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-propanoic acid
5-[1,2-Dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-propanoic acid
2-
2-
3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-(1-piperidin-4-ylpyrazol-4-yl)pyridin-2-amine
3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-(1-piperidin-4-ylpyrazol-4-yl)pyridin-2-amine
N-(4-((6,7-Dimethoxyquinolin-4-yl)oxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
N-(4-((6,7-Dimethoxyquinolin-4-yl)oxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
(6-((5-Fluoro-2-((3,4,5-trimethoxyphenyl)amino)pyrimidin-4-yl)amino)-2,2-dimethyl-3-oxo-2H-pyrido[3,2-b][1,4]oxazin-4(3H)-yl)methyl dihydrogen phosphate, disodium
(6-((5-Fluoro-2-((3,4,5-trimethoxyphenyl)amino)pyrimidin-4-yl)amino)-2,2-dimethyl-3-oxo-2H-pyrido[3,2-b][1,4]oxazin-4(3H)-yl)methyl dihydrogen phosphate, disodium
3Z)-N-(3-Chlorophenyl)-3-({3,5-dimethyl-4-[(4-methylpiperazin-1-yl)carbonyl]-1H-pyrrol-2-yl}methylene)-N-methyl-2-oxo-2,3-dihydro-1H-indole-5-sulfonamide
Q-IE(OMe)-TD(OMe)-OPh; Quinolyl-Ile-Glu(OMe)-Thr-Asp(OMe)-OPh
3Z)-N-(3-Chlorophenyl)-3-({3,5-dimethyl-4-[(4-methylpiperazin-1-yl)carbonyl]-1H-pyrrol-2-yl}methylene)-N-methyl-2-oxo-2,3-dihydro-1H-indole-5-sulfonamide
N-Methyl-N’-(3-pyridinylbenzyl)-N’-(3-chlorobenzo[b]thiophene-2-carbonyl)-1,4-diaminocyclohexane
N-Methyl-N’-(3-pyridinylbenzyl)-N’-(3-chlorobenzo[b]thiophene-2-carbonyl)-1,4-diaminocyclohexane
(9β,13α,14β,20α)-3-Hydroxy-9,13-dimethyl-2-oxo-24,25,26-trinoroleana-1(10),3,5,7-tetraen-29-oic acid
(9β,13α,14β,20α)-3-Hydroxy-9,13-dimethyl-2-oxo-24,25,26-trinoroleana-1(10),3,5,7-tetraen-29-oic acid
N6-[2-[[4-(Diethylamino)-1-methylbutyl]amino]-6-methyl-4-pyrimidinyl]-2-methyl-4,6-quinolinediamine trihydrochloride
N6-[2-[[4-(Diethylamino)-1-methylbutyl]amino]-6-methyl-4-pyrimidinyl]-2-methyl-4,6-quinolinediamine trihydrochloride
Q-DEVD-Oph, Q-Asp-Glu-Val-Asp-Oph
Lup-20(29)-ene-3b,28-diol
Lup-20(29)-ene-3b,28-diol
Arginine N-methyltransferase inhibitor-1
Arginine N-methyltransferase inhibitor-1
3-[1-(Dimethylaminopropyl)indol-3-yl]-4-(indol-3-yl)maleimide; GF 109203X; G
3-[1-(Dimethylaminopropyl)indol-3-yl]-4-(indol-3-yl)maleimide; GF 109203X; G
2-{1-[3-(Amidinothio)propyl]-1H-indol-3-yl}-3-(1-methylindol-3-yl)maleimide methanesulfonate; Bisindolylmaleimide IX methanesulfonate; BIM IX
2-{1-[3-(Amidinothio)propyl]-1H-indol-3-yl}-3-(1-methylindol-3-yl)maleimide methanesulfonate; Bisindolylmaleimide IX methanesulfonate; BIM IX
3-[1-(Dimethylaminopropyl)indol-3-yl]-4-(indol-3-yl)maleimide hydrochloride; GF 109203X; G
3-[1-(Dimethylaminopropyl)indol-3-yl]-4-(indol-3-yl)maleimide hydrochloride; GF 109203X; G
(E)-4-(4-((5-(4,5-Dimethyl-2-nitrophenyl)furan-2-yl)-methylene)-3-methyl-5-oxo-4,5-dihydro-1H-pyrazol-1-yl)benzoic acid
(E)-4-(4-((5-(4,5-Dimethyl-2-nitrophenyl)furan-2-yl)-methylene)-3-methyl-5-oxo-4,5-dihydro-1H-pyrazol-1-yl)benzoic acid
(2S)-2-([(3,5-Difluorophenyl)acetyl]amino)-N-[(3S)-1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-3-yl]prop*
(2S)-2-([(3,5-Difluorophenyl)acetyl]amino)-N-[(3S)-1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-3-yl]prop*
(E)-4-((4-)1H-1,2,3-Triazol-1-yl)butyl)phenoxy)methyl)-2-(4-trifluoromethyl)oxazole; Mubritinib
(E)-4-((4-)1H-1,2,3-Triazol-1-yl)butyl)phenoxy)methyl)-2-(4-trifluoromethyl)oxazole; Mubritinib
4-(3-(4-(cycloprppanecarbonyl)piperazine-1-carbonyl)-4-fluorobenzyl)phthalazine-1(2H)-one; ADZ-2281; KU-59436
4-(3-(4-(cycloprppanecarbonyl)piperazine-1-carbonyl)-4-fluorobenzyl)phthalazine-1(2H)-one; ADZ-2281; KU-59436
Q-DEVD-Oph, Q-Asp-Glu-Val-Asp-Oph
N-[(4-Methoxyphenyl)methyl]-N’-(5-nitro-2-thiazolyl)urea
N-[(4-Methoxyphenyl)methyl]-N’-(5-nitro-2-thiazolyl)urea
1-(5-tert-Butyl-2-p-tolyl-2H-pyrazol-3-yl)-3-[4-(2-morpholin-4-yl-ethoxy)-naphthalen-1-yl]-urea; BRRB 796
1-(5-tert-Butyl-2-p-tolyl-2H-pyrazol-3-yl)-3-[4-(2-morpholin-4-yl-ethoxy)-naphthalen-1-yl]-urea; BRRB 796
(3R,5S,6E)-7-[4-(4-fluorophenyl)-2-(N-methylmethanesulfonamido)-6-(propan-2-yl)pyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid
(3R,5S,6E)-7-[4-(4-fluorophenyl)-2-(N-methylmethanesulfonamido)-6-(propan-2-yl)pyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid
N-[(5aR,6aS,7S,9Z,10aS)-9-[amino(hydroxy)methylidene]-4,7-bis(dimethylamino)-1,10a,12-trihydroxy-8,10,11-trioxo-5,5a,6,6a,7,8,9,10,10a,11-decahydrotetracen-2-yl]-2-(tert-butylamino)acetamide
N-[(5aR,6aS,7S,9Z,10aS)-9-[amino(hydroxy)methylidene]-4,7-bis(dimethylamino)-1,10a,12-trihydroxy-8,10,11-trioxo-5,5a,6,6a,7,8,9,10,10a,11-decahydrotetracen-2-yl]-2-(tert-butylamino)acetamide
3’,4’-Didehydro-4’-deoxy-C’-norvincaleukoblastine [R-(R,R)-2-3-dihydroxybutanedioate (1:2)salt], 5’-Noranhydrovinoblastine tartrate, KW-2307, NVB, Navelbine tartrate
3’,4’-Didehydro-4’-deoxy-C’-norvincaleukoblastine [R-(R,R)-2-3-dihydroxybutanedioate (1:2)salt], 5’-Noranhydrovinoblastine tartrate, KW-2307, NVB, Navelbine tartrate
Benz(G)isoquinoline-5,10-dione, 6,9-bis((2-aminoethyl)amino)-, (2Z)-2-butenedioate (1:2); BBR-2778

 



產(chǎn)品對比 二維碼

掃一掃訪問手機商鋪

對比框

在線留言
宝应县| 醴陵市| 任丘市| 青神县| 昌吉市| 大城县| 前郭尔| 五峰| 中宁县| 白银市| 忻州市| 神木县| 深圳市| 靖宇县| 边坝县| 广德县| 土默特右旗| 子洲县| 石门县| 读书| 孝感市| 甘南县| 文昌市| 辽宁省| 日照市| 滕州市| 平安县| 阜城县| 兰溪市| 凌云县| 台江县| 温泉县| 苗栗市| 西贡区| 榕江县| 安宁市| 台江县| 郸城县| 锦州市| 迭部县| 彭泽县|